Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ABSI


Fundamental

Company: Absci Corp
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -0.95
Insider Own: 12.69%
Shs Outstand: 149.52M
Perf Week: -22.08%
Market Cap: 498.66M
Forward P/E: -
EPS next Y: -0.67
Insider Trans: 0.83%
Shs Float: 134.95M
Perf Month: -16.83%
Enterprise Value: 372.40M
PEG: -
EPS next Q: -0.20
Inst Own: 60.78%
Short Float: 23.02%
Perf Quarter: 17.02%
Income: -113.30M
P/S: 120.45
EPS this Y: 7.45%
Inst Trans: 2.09%
Short Ratio: 5.95
Perf Half Y: 21.27%
Sales: 4.14M
P/B: 2.46
EPS next Y Percentage: 22.48%
ROA: -48.69%
Short Interest: 31.06M
Perf YTD: 27.29%
Book/sh: 1.36
P/C: 3.73
EPS next 5Y: 6.35%
ROE: -57.39%
52W High: 6.33 -47.31%
Perf Year: -17.65%
Cash/sh: 0.89
P/FCF: -
EPS past 3/5Y: 5.67% -29.30%
ROIC: -63.98%
52W Low: 2.01 65.92%
Perf 3Y: 14.21%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: -1.76% 17.09%
Gross Margin: -205.97%
Volatility W: 7.42%
Volatility M: 8.53%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 89.95
EPS Y/Y TTM: -1.34%
Oper. Margin: -2846.57%
ATR (14): 0.32
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 4.39
Sales Y/Y TTM: 27.32%
Profit Margin: -2737.94%
RSI (14): 38.96
Recom: 1.00
Dividend Gr. 3/5Y: - -
Current Ratio: 4.39
EPS Q/Q: -9.31%
SMA20: -21.19%
Beta: 2.16
Target Price: 8.13
Payout: -
Debt/Eq: 0.04
Sales Q/Q: -53.31%
SMA50: -2.54%
Rel Volume: 0.84
Prev Close: 3.59
Employees: 157
LT Debt/Eq: 0.02
Earnings: Nov 12 AMC
SMA200: 3.96%
Avg Volume: 5.22M
Price: 3.34
IPO: Jul 22, 2021
Option/Short: Yes / Yes
EPS/Sales Surpr.: -15.05% -52.83%
Trades:
Volume: 4,413,630
Change: -7.10%

Technical:


Latest News:

Analysts Have Conflicting Sentiments on These Healthcare Companies: AbSci (ABSI) and ... neutral
ABSI AMGN

Summary: Analysts weigh in on AbSci (ABSI) and Amgen (AMGN) in the Healthcare sector with price targets and ratings provided.

Full article
2024-05-20T15:43:14Z